Marvin Shauna A, Russier Marion, Huerta C Theodore, Russell Charles J, Schultz-Cherry Stacey
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Rhodes College, Memphis, Tennessee, USA.
J Virol. 2017 Jan 3;91(2). doi: 10.1128/JVI.01417-16. Print 2017 Jan 15.
Whether influenza virus replication in macrophages is productive or abortive has been a topic of debate. Utilizing a panel of 28 distinct human, avian, and swine influenza viruses, we found that only a small subset can overcome cellular blocks to productively replicate in murine and primary human macrophages. Murine macrophages have two cellular blocks. The first block is during viral entry, where virions with relatively acid-stable hemagglutinin (HA) proteins are rendered incapable of pH-induced triggering for membrane fusion, resulting in lysosomal degradation. The second block is downstream of viral replication but upstream of late protein synthesis. In contrast, primary human macrophages only have one cellular block that occurs after late protein synthesis. To determine the impact of abortive replication at different stages of the viral life cycle or productive replication on macrophage function, we assessed cytotoxicity, nitric oxide or reactive oxygen species production, and phagocytosis. Intriguingly, productive viral replication decreased phagocytosis of IgG-opsonized bioparticles and Fc receptor CD16 and CD32 surface levels, a function, to our knowledge, never before reported for an RNA virus. These data suggest that replication in macrophages affects cellular function and plays an important role in pathogenesis during infection in vivo IMPORTANCE: Macrophages are a critical first line of defense against respiratory pathogens. Thus, understanding how viruses evade or exploit macrophage function will provide greater insight into viral pathogenicity and antiviral responses. We previously showed that only a subset of highly pathogenic avian (HPAI) H5N1 influenza virus strains could productively replicate in murine macrophages through a hemagglutinin (HA)-mediated mechanism. These studies expand upon this work and demonstrate that productive replication is not specific to unique HPAI H5N1 viruses; an H1N1 strain (A/WSN/33) can also replicate in macrophages. Importantly, we identify two cellular blocks limiting replication that can be overcome by an avian-like pH of activation for nuclear entry and a yet-to-be-identified mechanism(s) to overcome a postnuclear entry block. Overcoming these blocks reduces the cell's ability to phagocytose IgG-opsonized bioparticles by decreasing Fc receptor surface levels, a mechanism previously thought to occur during bacterial and DNA viral infections.
流感病毒在巨噬细胞中的复制是有效还是无效一直是一个有争议的话题。我们使用一组28种不同的人、禽和猪流感病毒,发现只有一小部分病毒能够克服细胞障碍,在小鼠和原代人巨噬细胞中进行有效复制。小鼠巨噬细胞有两个细胞障碍。第一个障碍发生在病毒进入期间,具有相对酸稳定血凝素(HA)蛋白的病毒粒子无法通过pH诱导触发膜融合,导致溶酶体降解。第二个障碍在病毒复制下游但在晚期蛋白质合成上游。相比之下,原代人巨噬细胞只有一个细胞障碍,发生在晚期蛋白质合成之后。为了确定病毒生命周期不同阶段的无效复制或有效复制对巨噬细胞功能的影响,我们评估了细胞毒性、一氧化氮或活性氧的产生以及吞噬作用。有趣的是,有效的病毒复制降低了IgG调理生物颗粒的吞噬作用以及Fc受体CD16和CD32的表面水平,据我们所知,这一功能此前从未在RNA病毒中报道过。这些数据表明,在巨噬细胞中的复制会影响细胞功能,并在体内感染期间的发病机制中起重要作用。重要性:巨噬细胞是抵御呼吸道病原体的关键第一道防线。因此,了解病毒如何逃避或利用巨噬细胞功能将有助于更深入地了解病毒致病性和抗病毒反应。我们之前表明,只有一小部分高致病性禽流感(HPAI)H5N1流感病毒株能够通过血凝素(HA)介导的机制在小鼠巨噬细胞中进行有效复制。这些研究扩展了这项工作,并证明有效复制并非高致病性禽流感H5N1病毒所特有;一株H1N1病毒(A/WSN/33)也能在巨噬细胞中复制。重要的是,我们确定了两个限制复制的细胞障碍,一种类似禽源的激活pH值用于核进入可以克服第一个障碍,而克服核进入后障碍的机制尚待确定。克服这些障碍会通过降低Fc受体表面水平来降低细胞吞噬IgG调理生物颗粒的能力,这一机制此前被认为发生在细菌和DNA病毒感染期间。